MedPath

Evaluating Inhibitory Control Training to Reduce Aggression in Individuals with Co-occuring Substance Use and Gambling Disorders

Not Applicable
Conditions
Health Condition 1: F10-F19- Mental and behavioral disorders due to psychoactive substance useHealth Condition 2: F630- Pathological gambling
Registration Number
CTRI/2024/08/072033
Lead Sponsor
Yashita Ahluwalia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients seeking treatment from the Inpatient Department (IPD) at NDDTC, AIIMS.

2.Male Patients.

3.Patients diagnosed with substance use disorder in accordance with DSM-5, as per clinical history.

4.Patients qualifying the criteria of problem or pathological gambling in accordance with the score on South Oaks Gambling Screen (SOGS). A score of 1 to 4 suggests problem gambling while score of more than 4 indicates probable pathological gambling.

5.Patients must be willing to participate in the study. 6.Patients willing to attend follow-ups.

Exclusion Criteria

1.Patients with severe medical/ psychiatric illnesses that preclude their participation in the study, as per clinical history.

2.Patients with a lifetime history of a neurological illness, neurodevelopmental disorder, or traumatic head injury as per clinical history.

3.Patients not willing to participate or provide informed consent for the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Score on the Overt Aggression Scale – Modified (OAS-M).Timepoint: At 1 Month Follow Up.
Secondary Outcome Measures
NameTimeMethod
Score on the Overt Aggression Scale – Modified (OAS-M)Timepoint: At 3 Months Follow Up;Score on the South Oaks Gambling Scale (Item – 1) for each type of gambling behaviour engaged inTimepoint: At 1 Month Follow Up and 3 Months Follow Up;Score on the Timeline Follow Back Scale for each substance usedTimepoint: At 1 Month Follow Up and 3 Months Follow Up
© Copyright 2025. All Rights Reserved by MedPath